Five Hidden Stocks Betting on AI’s Next Phase Ahead
With AMD’s rally making headlines, a slate of overlooked names could ride the AI and defense cycle higher. Here are f...
Using Indices To Gauge Portfolio Risk
Indices offer a practical way to quantify risk exposure and monitor changes over time, supporting proactive adjustments.
27,018 articles
Retiring Comes with $172,500 Medical Bill: Medicare Gaps
A new Fidelity study finds that a 65-year-old today may incur about $172,500 in lifetime medical costs, excluding lon...
What Happens Dividend Income When a Recession Hits
Dividend income can weather downturns better than stocks, but it isn’t immune. This report explains why payouts hold ...
This Billionaire Was Right on D-Wave, but the Ride Continues
A billionaire investor backed D-Wave Quantum in late 2024, and the stock has surged and slumped in a choppy 2026 trad...
Stock Split Watch: Lilly — Is Eli Lilly Next to Split?
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Thought COBRA Counted Coverage? Medicare Penalties Persist
A common retirement pitfall hinges on COBRA coverage not extending Medicare enrollment windows. This piece explains h...
XLP’s 2.6% Yield Holds Steady as Retail Sales Rally Broadens
April retail sales rose 0.5% to $757.1 billion, lifting cash flow for consumer staples stocks. The ETF’s yield remain...
AMLP vs MLPX: Which Midstream ETF Pays More in 2026
Two leading midstream ETFs, AMLP and MLPX, battle for income and tax efficiency as the 2026 energy rally persists. Th...
Wells Fargo Raises Targets on UNFI as MTDR Gains Follow
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
Palantir’s Forged Connection with Investors via Letters
Palantir’s CEO has shifted away from traditional earnings calls, instead sending quarterly shareholder letters that m...
Maxed TSMC, Samsung Hynix: EM Funds Hunt New Bets Today
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status